GlaxoSmithKline Pharmaceuticals Limited

NSE GLAXO.NS

GlaxoSmithKline Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2024: 58.89%

GlaxoSmithKline Pharmaceuticals Limited Gross Profit Margin is 58.89% for the year ending March 31, 2024, a -2.64% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

GlaxoSmithKline Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2023 was 60.49%, a 8.44% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2022 was 55.78%, a -1.11% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2021 was 56.40%, a -0.45% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Gross Profit Margin for the year ending March 31, 2020 was 56.66%, a 5.27% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

NSE: GLAXO.NS

GlaxoSmithKline Pharmaceuticals Limited

CEO	Mr. Bhushan Akshikar
IPO Date	July 1, 2002
Location	India
Headquarters	GSK House
Employees	3,211
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact, Tenovate, Flutivate, Physiogel, Zimig, Cobadex CZS, Infanrix Hexa, Synflorix, Supacef, Havrix, Menveo, Boostrix, Fluarix Tetra, Varilrix, Nucala, and Trelegy Ellipta brands. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.

Key trends

Past 5 years